Skip to content
2000
Volume 9, Issue 2
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

The standard gold care medications for benign prostatic hyperplasia (BPH) are the alpha-1-adrenergic antagonists, they are an effective medications and are generally well tolerated. However, at this time, no data have been published concerning the development of severe rhinorrhea with a great impact on quality of life in patients treated with alpha-1-adrenergic antagonists. We report two men with BPH treated with two different alpha-adrenergic antagonists; alfuzosin and doxazocin. The naranjo quality scale documented a probable adverse drug reaction (score 7) between rhinorrhea and treatmenr with alpha-1-adrenergic antagonists. In conclusion we reported that alpha-1-adrenergic antagonists are able to induce rhinorrhea in patients with BPH.

Loading

Article metrics loading...

/content/journals/cds/10.2174/1574886309666140527112408
2014-07-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/cds/10.2174/1574886309666140527112408
Loading

  • Article Type:
    Research Article
Keyword(s): Benign prostatic hyperplasia (BPH); lower urinary tract symptoms (LUTS)
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test